Bioassay-guided isolation of two antifungal compounds from Magnolia officinalis, and the mechanism of action of honokiol
Yin-Fang Yan,Cheng-Jie Yang,Xiao-Fei Shang,Zhong-Min Zhao,Ying-Qian Liu,Rui Zhou,Hua Liu,Tian-Lin Wu,Wen-Bin Zhao,Yu-Ling Wang,Guan-Fang Hu,Fang Qin,Ying-Hui He,Hai-Xin Li,Sha-Sha Du
DOI: https://doi.org/10.1016/j.pestbp.2020.104705
IF: 4.966
2020-11-01
Pesticide Biochemistry and Physiology
Abstract:<p><em>Magnolia officinalis</em>, as a well-known herb worldwide, has been widely used to treat multiple diseases for a long time. In this study, the petroleum ether extract from <em>M. officinalis</em> showed effective antifungal activity against seven plant pathogens (particularly against <em>R. solani</em> with an inhibition rate of 100.00% at 250 μg/mL). Honokiol and magnolol, isolated by the bioassay-guided method, exhibited greater antifungal activity than tebuconazole (EC<sub>50</sub> = 3.07 μg/mL, <em>p</em> ≤ 0.001) against <em>R. solani</em>, which EC<sub>50</sub> values were 2.18 μg/mL and 3.48 μg/mL, respectively. We used transcriptomics to explore the mechanism of action of honokiol against <em>R. solani</em>. Results indicated that honokiol may exert antifungal effects by blocking the oxidative phosphorylation metabolic pathway. Further studies indicated that honokiol induced ROS overproduction, disrupted the mitochondrial function, affected respiration, and blocked the TCA cycle, which eventually inhibited ATP production. Besides, honokiol also damaged cell membranes and caused morphological changes. This study demonstrated that the lignans isolated from <em>M. officinalis</em> possess the potential to be developed as botanical fungicides.</p>
biochemistry & molecular biology,entomology,physiology